Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -97.47% is 43% below its 5-year average of -68.31%, near the high end of its 5-year range (-837.09%–-11.69%).
As of the fiscal period ended Saturday, July 4, 2026. 6.67% below its 12-month average of -91.38%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-07-04): -97.47%.
RETURN ON EQUITY (ROE)
-97.47%
RETURN ON EQUITY (ROE) AVG TTM
-91.38%
RETURN ON EQUITY (ROE) AVG 3Y
-171.84%
RETURN ON EQUITY (ROE) AVG 5Y
-68.31%
RETURN ON EQUITY (ROE) AVG 10Y
-48.44%
RETURN ON EQUITY (ROE) AVG 15Y
-26.72%
RETURN ON EQUITY (ROE) AVG 20Y
-27.60%
CURRENT VS TTM AVG
-6.67%
CURRENT VS 3Y AVG
+43.28%
CURRENT VS 5Y AVG
-42.69%
CURRENT VS 10Y AVG
-101.23%
CURRENT VS 15Y AVG
-264.84%
CURRENT VS 20Y AVG
-253.14%
SECTOR MEDIAN · HEALTHCARE
-38.51%
median of 487 covered companies
CURRENT VS SECTOR MEDIAN
-153.11%
vs the sector median at left
IRIDEX Corporation
Market Cap
$12.12M
Return on Equity (ROE)
-97.47%
TTM Avg
-91.38%
3Y Avg
-171.84%
5Y Avg
-68.31%
Market Cap
$11.83M
Return on Equity (ROE)
N/A
TTM Avg
-180.04%
3Y Avg
-6461.50%
5Y Avg
-4315.55%
Market Cap
$11.50M
Return on Equity (ROE)
-37052.06%
TTM Avg
-237.80%
3Y Avg
-258.91%
5Y Avg
-310.30%
Market Cap
$11.81M
Return on Equity (ROE)
N/A
TTM Avg
-162.71%
3Y Avg
-135.96%
5Y Avg
-98.83%
Market Cap
$12.74M
Return on Equity (ROE)
N/A
TTM Avg
-201.97%
3Y Avg
-21.23%
5Y Avg
365.72%
Market Cap
$11.47M
Return on Equity (ROE)
-177.35%
TTM Avg
-89.62%
3Y Avg
-75.99%
5Y Avg
-59.80%
Market Cap
$11.23M
Return on Equity (ROE)
-65.18%
TTM Avg
-26.62%
3Y Avg
-94.28%
5Y Avg
-90.35%
Market Cap
$11.11M
Return on Equity (ROE)
-106.87%
TTM Avg
-250.57%
3Y Avg
-230.96%
5Y Avg
-240.83%
Market Cap
$11.12M
Return on Equity (ROE)
-214.92%
TTM Avg
-46.13%
3Y Avg
-156.76%
5Y Avg
-652.77%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $12.12M | -97.47% | -91.38% | -171.84% | -68.31% |
| Lantern Pharma Inc. (LTRN)vs › | $11.83M | N/A | -180.04% | -6461.50% | -4315.55% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.50M | -37052.06% | -237.80% | -258.91% | -310.30% |
| Cytosorbents Corporation (CTSO)vs › | $11.81M | N/A | -162.71% | -135.96% | -98.83% |
| Dare Bioscience, Inc. (DARE)vs › | $12.74M | N/A | -201.97% | -21.23% | 365.72% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.47M | -177.35% | -89.62% | -75.99% | -59.80% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.23M | -65.18% | -26.62% | -94.28% | -90.35% |
| Biofrontera Inc. (BFRI)vs › | $11.11M | -106.87% | -250.57% | -230.96% | -240.83% |
| BioVie Inc. (BIVI)vs › | $11.12M | -214.92% | -46.13% | -156.76% | -652.77% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.61M | -85.82% | -222.53% | -140.00% | -73.12% |
ROE
-97.5%
ROA
-13.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-07-04 | -97.47% |
| 2026-04-04 | -69.21% |
| 2026-01-03 | -90.15% |
| 2025-09-27 | -108.67% |
| 2025-06-28 | -89.90% |
| 2025-03-29 | -837.09% |
| 2024-12-31 | -424.89% |
| 2024-09-28 | -420.74% |
| 2024-06-29 | -255.70% |
| 2024-03-30 | -168.68% |
| 2023-12-31 | -100.50% |
| 2023-09-30 | -64.31% |
| 2023-07-01 | -57.78% |
| 2023-04-01 | -45.62% |
| 2022-12-31 | -43.80% |
| 2022-10-01 | -48.92% |
| 2022-07-02 | -47.55% |
| 2022-04-02 | -26.29% |
| 2021-12-31 | -22.43% |
| 2021-10-02 | -11.69% |
| 2021-07-03 | -9.36% |
| 2021-04-03 | -26.08% |
| 2020-12-31 | -36.44% |
| 2020-09-26 | -44.70% |
| 2020-06-27 | -41.38% |
| 2020-03-28 | -35.07% |
| 2019-12-31 | -38.82% |
| 2019-09-28 | -42.14% |
| 2019-06-29 | -44.47% |
| 2019-03-30 | -44.67% |
| 2018-12-31 | -42.77% |
| 2018-09-29 | -46.34% |
| 2018-06-30 | -61.94% |
| 2018-03-31 | -53.58% |
| 2017-12-31 | -42.16% |
| 2017-09-30 | -52.78% |
| 2017-07-01 | -42.84% |
| 2017-04-01 | -34.33% |
| 2016-12-31 | -29.91% |
| 2016-10-01 | -1.33% |
| 2016-07-02 | 1.89% |
| 2016-04-02 | 0.96% |
| 2015-12-31 | 1.41% |
| 2015-10-03 | 26.81% |
| 2015-07-04 | 26.63% |
| 2015-04-04 | 28.81% |
| 2014-12-31 | 29.75% |
| 2014-09-27 | 6.58% |
| 2014-06-28 | 6.71% |
| 2014-03-29 | 6.94% |
| 2013-12-31 | 8.63% |
| 2013-09-28 | 8.22% |
| 2013-06-29 | 3.24% |
| 2013-03-30 | 3.06% |
| 2012-12-31 | 6.56% |
| 2012-09-29 | 8.34% |
| 2012-06-30 | 12.42% |
| 2012-03-31 | 15.04% |
| 2011-12-31 | 11.64% |
| 2011-10-01 | 12.33% |
| 2011-07-02 | 15.22% |
| 2011-04-02 | 15.71% |
| 2010-12-31 | 15.68% |
| 2010-10-02 | 14.80% |
| 2010-07-03 | 14.17% |
| 2010-04-03 | 18.19% |
| 2009-12-31 | 17.20% |
| 2009-10-03 | -30.96% |
| 2009-07-04 | -39.28% |
| 2009-04-04 | -51.52% |
| 2008-12-31 | -62.74% |
| 2008-09-27 | -91.49% |
| 2008-06-28 | -95.69% |
| 2008-03-29 | -101.86% |
| 2007-12-31 | -118.41% |
| 2007-09-29 | -29.83% |
| 2007-06-30 | -33.43% |
| 2007-03-31 | -34.26% |
| 2006-12-31 | -17.77% |
| 2006-09-30 | -4.43% |
| 2006-07-01 | 1.30% |
| 2006-04-01 | 4.01% |
| 2005-12-31 | 4.84% |
| 2005-10-01 | 4.41% |
| 2005-07-02 | -0.33% |
| 2005-04-02 | -1.27% |
| 2004-12-31 | -1.26% |
| 2004-10-02 | -0.36% |
| 2004-07-03 | 2.73% |
| 2004-04-03 | 1.38% |
| 2003-12-31 | 1.20% |
| 2003-09-27 | 1.58% |
| 2003-06-28 | 1.42% |
